Francisco Sala

Francisco Sala

Auto-generated profile, based on publicly available information

Francisco Sala

Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, 03050 Sant Joan d'Alacant, Spain

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 1990 in Science
Verified
Journal Article
Closed access
PDF file
AHArturo Hernández-Cruz
Arturo Hernández-Cruz
FSFrancisco Sala
Francisco Sala
PAPaul R. Adams
Paul R. Adams
Confocal laser-scanned microscopy and long-wavelength calcium (Ca 2+ ) indicators were combined to monitor both sustained and rapidly dissipating Ca 2+ gradients in voltage-clamped sympathetic neurons isolated from the bullfrog. After a brief activation of voltage-dependent Ca 2+ channels, Ca 2+ spreads inwardly, and reaches the center of these spherical cells in about 300 milliseconds. Although the Ca 2+ redistribution in the bulk of the cytosol could be accounted for with a radial diffusion model, local nonlinearities, suggesting either nonuniform Ca 2+ entry or spatial buffering, could be seen. After electrical stimulation, Ca 2+ signals in the nucleus were consistently larger and decayed more slowly than those in the cytosol. A similar behavior was observed when release of intracellular Ca 2+ was induced by caffeine, suggesting that in both cases large responses originate from Ca 2+ release sites near or within the nucleus. These results are consistent with an amplification mechanism involving Ca 2+ -induced Ca 2+ release, which could be relevant to activity-dependent, Ca 2+ -regulated nuclear events.

19 November 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
María Salud García-GutiérrezMaría Salud García-Gutiérrez
María Salud García-Gutiérrez
Francisco NavarreteFrancisco Navarrete
Francisco Navarrete
Ani GasparyanAni Gasparyan
Ani Gasparyan
AAAmaya Austrich-Olivares
Amaya Austrich-Olivares
FSFrancisco Sala
Francisco Sala
Jorge ManzanaresJorge Manzanares
Jorge Manzanares
The potential therapeutic use of some Cannabis sativa plant compounds has been attracting great interest, especially for managing neuropsychiatric disorders due to the relative lack of efficacy of the current treatments. Numerous studies have been carried out using the main phytocannabinoids, tetrahydrocannabinol (THC) and cannabidiol (CBD). CBD displays an interesting pharmacological profile without the potential for becoming a drug of abuse, unlike THC. In this review, we focused on the anxiolytic, antidepressant, and antipsychotic effects of CBD found in animal and human studies. In rodents, results suggest that the effects of CBD depend on the dose, the strain, the administration time course (acute vs. chronic), and the route of administration. In addition, certain key targets have been related with these CBD pharmacological actions, including cannabinoid receptors (CB1r and CB2r), 5-HT1A receptor and neurogenesis factors. Preliminary clinical trials also support the efficacy of CBD as an anxiolytic, antipsychotic, and antidepressant, and more importantly, a positive risk-benefit profile. These promising results support the development of large-scale studies to further evaluate CBD as a potential new drug for the treatment of these psychiatric disorders.

1 February 1990 in Biophysical Journal
Verified
Journal Article
Closed access
FSF. Sala
F. Sala
AHA. Hernández-Cruz
A. Hernández-Cruz

1 May 1984 in Nature
Verified
Journal Article
Closed access
ADANTONIO M GARCIA DE DIEGO
ANTONIO M GARCIA DE DIEGO
FSF. Sala
F. Sala
JRJ. A. Reig
J. A. Reig
SVS. Viniegra
S. Viniegra
JFJ. Frías
J. Frías
ASAs
As

1 September 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SHSarah Halevi
Sarah Halevi
LYLina Yassin
Lina Yassin
MEMargalit Eshel
Margalit Eshel
FSFrancisco Sala
Francisco Sala
SSSalvador Sala
Salvador Sala
MTMillet Treinin
Millet Treinin
In Caenorhabditis elegans, the ric-3 gene is required for the maturation of multiple nicotinic acetylcholine receptors (nAChRs), whereas other neurotransmittergated channels expressed within the same cells are unaffected by the presence of RIC-3. Here we show that RIC-3 is a member of a conserved gene family with representatives in both vertebrates and invertebrates. All members of this family have two transmembrane domains followed by a coiled-coil domain. Expression of the human ric-3 homolog, hric3, like the C. elegans ric-3, enhances C. elegans DEG-3/DES-2, rat α7, and human α7 nAChR-dependent whole-cell current amplitudes in Xenopus leavis oocytes, thus demonstrating functional conservation. However, hric3 also reduces human α4β2 and α3β4 nAChR-dependent whole-cell current amplitudes. Thus, hric3 shows differential effects on human nAChRs unlike the observed uniform effect of ric-3 on C. elegans nAChRs. Moreover, hric3 totally abolished currents evoked by 5-HT3 serotonin receptors, whereas it barely modified α1 glycine receptor currents. With this caveat, RIC-3 belongs to a conserved family of genes likely to regulate nAChR-mediated transmission throughout evolution. Analysis of transcripts encoded by the hric3 locus shows that it encodes for multiple transcripts, likely to produce multiple hric3 isoforms, and that hric3 is expressed in neurons and muscles, thus enabling its interactions with nAChRs in vivo.

1 February 1997 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
ACAntonio Campos-Caro
Antonio Campos-Caro
FSF. I. Smillie
F. I. Smillie
ETE. Domínguez del Toro
E. Domínguez del Toro
JRJ. C. Rovira
J. C. Rovira
FVF. Vicente‐Agulló
F. Vicente‐Agulló
MCM. Criado
M. Criado
Neuronal nicotinic acetylcholine receptors from bovine adrenomedullary chromaffin cells play a primary role in triggering catecholamine secretion. In the present study, their constituent subunits were characterized. In addition to the α3 subunit, which we have previously cloned, the presence of α5 and β4 but not of β2 subunits was detected by reverse transcription‐PCR analysis of mRNA from adrenal medulla. In situ hybridization indicated that α3, α5, and β4 subunits are coexpressed in all chromaffin cells. The primary structure of α5 and β4 subunits was determined and functional receptors were obtained upon coinjection of subunit cRNAs into Xenopus oocytes. In contrast to other β4‐containing nicotinic receptors, the ones formed by the bovine β4 subunit are insensitive to the agonist cytisine. Finally, we characterized the intergenic region of α3 and α5 subunits, which together with the β4 subunit, form a gene cluster in rats and chickens. RNase assays and the existence of overlapping cDNAs indicate that, in the bovine genome, the α3 and α5 genes overlap at their 3′ ends. This fact is probably due to inefficient transcription termination, as a result of weak polyadenylation signals.